Persistence Market Research Company
Customize Now Get FREE Sample

Treatment Syndromes Dementia Movement Disorders Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Treatment Syndromes Dementia Movement Disorders Market by Treatment Type (Pharmacological Treatments, Non-Pharmacological Treatments, Surgical and Interventional, Complementary & Supportive Therapies), Condition Type (Alzheimer’s Disease, Parkinson’s Disease, Lewy Body Dementia, Frontotemporal Dementia, Vascular Dementia, Others), End User (Hospitals, Specialty Clinics, Outpatient Clinics, Rehabilitation Centers, Others), and Regional Analysis from 2026 to 2033

ID: PMRREP2833| 182 Pages | 8 Jan 2026 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Treatment Syndromes Dementia Movement Disorders Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 - 2033, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Regulatory Landscape
    2. Product Adoption Analysis
    3. Value Chain Analysis
    4. Key Deals and Mergers
    5. PESTLE Analysis
    6. Porter’s Five Force Analysis
  4. Global Treatment Syndromes Dementia Movement Disorders Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2025
      2. Market Size (US$ Bn) Analysis and Forecast, 2026-2033
    3. Global Treatment Syndromes Dementia Movement Disorders Market Outlook: Treatment Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Treatment Type, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2026 - 2033
        1. Pharmacological Treatments
          1. Cholinesterase Inhibitors
          2. MAO Inhibitors
          3. Glutamate Inhibitors
          4. Antipsychotics
          5. Other Drug Class
        2. Non-Pharmacological Treatments
        3. Surgical and Interventional
        4. Complementary & Supportive Therapies
      4. Market Attractiveness Analysis: Treatment Type
    4. Global Treatment Syndromes Dementia Movement Disorders Market Outlook: Condition Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Condition Type, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Condition Type, 2026 - 2033
        1. Alzheimer’s Disease
        2. Parkinson’s Disease
        3. Lewy Body Dementia
        4. Frontotemporal Dementia
        5. Vascular Dementia
        6. Others
      4. Market Attractiveness Analysis: Condition Type
    5. Global Treatment Syndromes Dementia Movement Disorders Market Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End User, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
        1. Hospitals
        2. Specialty Clinics / Neurology Centers
        3. Outpatient Clinics
        4. Rehabilitation Centers
        5. Others
      4. Market Attractiveness Analysis: End User
  5. Global Treatment Syndromes Dementia Movement Disorders Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Region, 2020 - 2025
    3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2026 - 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Treatment Syndromes Dementia Movement Disorders Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Treatment Type
      3. By Condition Type
      4. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. U.S.
      2. Canada
    4. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2026 - 2033
      1. Pharmacological Treatments
        1. Cholinesterase Inhibitors
        2. MAO Inhibitors
        3. Glutamate Inhibitors
        4. Antipsychotics
        5. Other Drug Class
      2. Non-Pharmacological Treatments
      3. Surgical and Interventional
      4. Complementary & Supportive Therapies
    5. Market Size (US$ Bn) Analysis and Forecast, By Condition Type, 2026 - 2033
      1. Alzheimer’s Disease
      2. Parkinson’s Disease
      3. Lewy Body Dementia
      4. Frontotemporal Dementia
      5. Vascular Dementia
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Hospitals
      2. Specialty Clinics / Neurology Centers
      3. Outpatient Clinics
      4. Rehabilitation Centers
      5. Others
    7. Market Attractiveness Analysis
  7. Europe Treatment Syndromes Dementia Movement Disorders Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Treatment Type
      3. By Condition Type
      4. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2026 - 2033
      1. Pharmacological Treatments
        1. Cholinesterase Inhibitors
        2. MAO Inhibitors
        3. Glutamate Inhibitors
        4. Antipsychotics
        5. Other Drug Class
      2. Non-Pharmacological Treatments
      3. Surgical and Interventional
      4. Complementary & Supportive Therapies
    5. Market Size (US$ Bn) Analysis and Forecast, By Condition Type, 2026 - 2033
      1. Alzheimer’s Disease
      2. Parkinson’s Disease
      3. Lewy Body Dementia
      4. Frontotemporal Dementia
      5. Vascular Dementia
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Hospitals
      2. Specialty Clinics / Neurology Centers
      3. Outpatient Clinics
      4. Rehabilitation Centers
      5. Others
    7. Market Attractiveness Analysis
  8. East Asia Treatment Syndromes Dementia Movement Disorders Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Treatment Type
      3. By Condition Type
      4. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2026 - 2033
      1. Pharmacological Treatments
        1. Cholinesterase Inhibitors
        2. MAO Inhibitors
        3. Glutamate Inhibitors
        4. Antipsychotics
        5. Other Drug Class
      2. Non-Pharmacological Treatments
      3. Surgical and Interventional
      4. Complementary & Supportive Therapies
    5. Market Size (US$ Bn) Analysis and Forecast, By Condition Type, 2026 - 2033
      1. Alzheimer’s Disease
      2. Parkinson’s Disease
      3. Lewy Body Dementia
      4. Frontotemporal Dementia
      5. Vascular Dementia
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Hospitals
      2. Specialty Clinics / Neurology Centers
      3. Outpatient Clinics
      4. Rehabilitation Centers
      5. Others
    7. Market Attractiveness Analysis
  9. South Asia & Oceania Treatment Syndromes Dementia Movement Disorders Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Treatment Type
      3. By Condition Type
      4. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2026 - 2033
      1. Pharmacological Treatments
        1. Cholinesterase Inhibitors
        2. MAO Inhibitors
        3. Glutamate Inhibitors
        4. Antipsychotics
        5. Other Drug Class
      2. Non-Pharmacological Treatments
      3. Surgical and Interventional
      4. Complementary & Supportive Therapies
    5. Market Size (US$ Bn) Analysis and Forecast, By Condition Type, 2026 - 2033
      1. Alzheimer’s Disease
      2. Parkinson’s Disease
      3. Lewy Body Dementia
      4. Frontotemporal Dementia
      5. Vascular Dementia
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Hospitals
      2. Specialty Clinics / Neurology Centers
      3. Outpatient Clinics
      4. Rehabilitation Centers
      5. Others
    7. Market Attractiveness Analysis
  10. Latin America Treatment Syndromes Dementia Movement Disorders Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Treatment Type
      3. By Condition Type
      4. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2026 - 2033
      1. Pharmacological Treatments
        1. Cholinesterase Inhibitors
        2. MAO Inhibitors
        3. Glutamate Inhibitors
        4. Antipsychotics
        5. Other Drug Class
      2. Non-Pharmacological Treatments
      3. Surgical and Interventional
      4. Complementary & Supportive Therapies
    5. Market Size (US$ Bn) Analysis and Forecast, By Condition Type, 2026 - 2033
      1. Alzheimer’s Disease
      2. Parkinson’s Disease
      3. Lewy Body Dementia
      4. Frontotemporal Dementia
      5. Vascular Dementia
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Hospitals
      2. Specialty Clinics / Neurology Centers
      3. Outpatient Clinics
      4. Rehabilitation Centers
      5. Others
    7. Market Attractiveness Analysis
  11. Middle East & Africa Treatment Syndromes Dementia Movement Disorders Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Treatment Type
      3. By Condition Type
      4. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2026 - 2033
      1. Pharmacological Treatments
        1. Cholinesterase Inhibitors
        2. MAO Inhibitors
        3. Glutamate Inhibitors
        4. Antipsychotics
        5. Other Drug Class
      2. Non-Pharmacological Treatments
      3. Surgical and Interventional
      4. Complementary & Supportive Therapies
    5. Market Size (US$ Bn) Analysis and Forecast, By Condition Type, 2026 - 2033
      1. Alzheimer’s Disease
      2. Parkinson’s Disease
      3. Lewy Body Dementia
      4. Frontotemporal Dementia
      5. Vascular Dementia
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Hospitals
      2. Specialty Clinics / Neurology Centers
      3. Outpatient Clinics
      4. Rehabilitation Centers
      5. Others
    7. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. AbbVie Inc.
        1. Overview
        2. Segments and Products
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Acorda Therapeutics Inc.
      3. Acadia Pharmaceuticals Inc.
      4. Amgen Inc.
      5. Amneal Pharmaceuticals Inc.
      6. AstraZeneca Plc
      7. Axovant Gene Therapies
      8. Bausch Health Companies Inc.
      9. Biogen Inc.
      10. Bristol-Myers Squibb Company
      11. Eisai Co., Ltd.
      12. Eli Lilly and Company
      13. F. Hoffmann-La Roche Ltd.
      14. GlaxoSmithKline plc
      15. H. Lundbeck A/S
      16. Others
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate